New Technology at CMH

CMH recently acquired two new pieces of technology that will improve patients’ comfort.

AccuVein

Do you know anyone who likes having their blood drawn? We don’t.

So, to make you more comfortable and to prevent multiple needle pricks, we are implementing the AccuVein AV400 vein illumination system in the surgery, medical/surgical and critical AccuVeincare units of the hospital, and in the CMH-OHSU Knight Cancer Collaborative. This system helps caregivers find veins for taking blood or intravenous treatments (venipuncture). It projects a safe beam of light onto your arm to reveal a map of the veins beneath the skin’s surface. 

According to research, up to one in three venipunctures fail the first time. And with about 2.7 million venipunctures done daily in the U.S., that’s a lot of sore arms. However, using the AccuVein system should help CMH caregivers prevent additional needle sticks, even when your veins are difficult to find.

Cepheid GeneXpert System

When your doctor has ordered a lab test, you want fast and accurate results. The CMH Laboratory is now using the Cepheid GeneXpert® System, which uses molecular diagnostics to detect microorganisms like viruses and bacteria in blood and urine.

“This new instrument can amplify a tiny amount of DNA from our from our target sample and make it easier to identify,” said Twilla McElmurry, lab manager. “The sensitivity and specificity are nearly 100 percent with this new method.”

Ribbon cutting for lab technologySamples that might have been sent to remote labs can now be done at CMH with very accurate results, McElmurry said. The system quickly identifies infectious diseases, including influenza, Methycillin-resistant Staphlyococcus aureus (MRSA), and Clostridium difficile — which means patients can be started on appropriate treatments sooner.

It’s our goal that with the use of both new technologies, patients will experience a more comfortable, easy and quick visit to the hospital.